ATLAS fair value
ATLAS has no fair value for this stock today.
Fresenius Medical Care AG & Co. stock price today, ATLAS forecast and fair value
Healthcare · Medical Care Facilities · Xetra (Deutsche Börse) · Germany
Prices as of Oct 27, 2026 · EUR
ATLAS has no fair value for this stock today.
51%
that it ends higher than today in 21 sessions
ATLAS's own quantitative analysis, all in one place.
Plans from €3.99 a month.
ATLAS's model gives Fresenius Medical Care AG & Co. a 51% chance of finishing higher a month from now (21 trading sessions) than today: close to a coin flip.
In half of the simulated outcomes the price ends between €38.61 and €42.81; in 9 out of 10, between €35.24 and €46.90. Estimated annual volatility is 30%.
ATLAS does not publish a fair value for FME.XETRA right now, but it does show its odds of rising: close to a coin flip.
Over the last 52 weeks FME.XETRA has traded between €34.57 and €47.54. Today it is 14.7% below that high and 17% above its low.
On the business: net margin is 4.8%; it trades at 11.9 times earnings.
Its beta is 0.81: it tends to move less than the market.
Fresenius Medical Care AG provides dialysis and related services for individuals with renal diseases in Germany, the United States, and internationally.
Want to see everything about Fresenius Medical Care AG & Co.?
Get started →Plans from €3.99 a month.
Other companies in the same line of business:
Fresenius Medical Care AG provides dialysis and related services for individuals with renal diseases in Germany, the United States, and internationally.
51%: close to a coin flip. In half of the simulated outcomes, FME.XETRA ends the month between €38.61 and €42.81.
Fresenius Medical Care AG & Co.'s market capitalization is €10.5B. Its price-to-earnings (P/E) ratio is 11.9: you pay €11.9 for each €1.00 of yearly earnings.
Yes. FME.XETRA's current dividend yield is 3.82% at today's price (€40.57).
Not investment advice. ATLAS estimates are produced by statistical models from public data; they can be wrong and past performance does not predict future results. Consider your own situation before investing. Disclaimer
ATLAS Signals
The week in the market, three stocks on ATLAS’s radar and what comes next. Get it every Monday.
By subscribing you agree to receive ATLAS Signals by email every Monday. You can unsubscribe with one click at any time. Privacy